These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3030349

  • 1. Epstein-Barr virus seroepidemiology in China.
    Zeng Y, Pi GH, Deng H, Zhang JM, Wang PC, Wolf H, De Thé G.
    AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
    [Abstract] [Full Text] [Related]

  • 2. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 3. Serological survey of nasopharyngeal carcinoma in 21 cities of south China.
    Deng H, Zeng Y, Lei Y, Zhao Z, Wang P, Li B, Pi Z, Tan B, Zheng Y, Pan W.
    Chin Med J (Engl); 1995 Apr 15; 108(4):300-3. PubMed ID: 7789220
    [Abstract] [Full Text] [Related]

  • 4. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W, Cao SM, Huang QH, Li YH, Deng MQ.
    Ai Zheng; 2009 Jan 15; 28(1):57-9. PubMed ID: 19448418
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Jan 15; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX.
    Anticancer Res; 2001 Jan 15; 21(4B):3021-9. PubMed ID: 11712805
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M, Ikegami N, Chatani M, Yoshino K, Sato T.
    Biken J; 1987 Jun 15; 30(2):45-51. PubMed ID: 2830879
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK, Vlantis AC, Ho RW, Tam JS, To KF, van Hasselt CA.
    Head Neck; 2004 Jul 15; 26(7):598-602. PubMed ID: 15229902
    [Abstract] [Full Text] [Related]

  • 15. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China.
    Zeng Y, Zhong JM, Li LY, Wang PZ, Tang H, Ma YR, Zhu JS, Pan WJ, Liu YX, Wei ZN.
    Intervirology; 1983 Jul 15; 20(4):190-4. PubMed ID: 6317603
    [Abstract] [Full Text] [Related]

  • 16. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients].
    Ji MF, Guo YQ, Liang JS, Zheng SA, Cheng WM, Yu BH, Ou XT, Wang DK.
    Zhonghua Zhong Liu Za Zhi; 2003 May 15; 25(3):243-5. PubMed ID: 12839685
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
    Liu MY, Chang YL, Ma J, Yang HL, Hsu MM, Chen CJ, Chen JY, Yang CS.
    J Med Virol; 1997 Jul 15; 52(3):262-9. PubMed ID: 9210034
    [Abstract] [Full Text] [Related]

  • 18. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
    Jiang LN, Dai LC, He JF, Chen YW, Ma ZH.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun 15; 20(2):30-2. PubMed ID: 16816858
    [Abstract] [Full Text] [Related]

  • 19. [The usefulness of serum antibody to Epstein-Barr virus-specific DNAase (EDAb) in early detection of nasopharyngeal carcinoma].
    Huang D.
    Zhonghua Zhong Liu Za Zhi; 1993 Jul 15; 15(4):289-91. PubMed ID: 8174467
    [Abstract] [Full Text] [Related]

  • 20. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
    Wan Z, Pi G, Sun N.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar 15; 12(1):74-6. PubMed ID: 12515179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.